Laddar...
Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
Our previous studies demonstrated that specific inhibition of the BIG3-PHB2 complex, which is a critical modulator in estrogen (E2) signaling, using ERAP, a dominant negative peptide inhibitor, leads to suppression of E2-dependent estrogen receptor (ER) alpha activation through the reactivation of t...
Sparad:
| I publikationen: | Cancer Sci |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BlackWell Publishing Ltd
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452155/ https://ncbi.nlm.nih.gov/pubmed/25736224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12654 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|